Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP)

Autor: Riccardo Fodde, S. Kloosterman, Nicoline Hoogerbrugge, Jeanine J. Houwing-Duistermaat, S. Verhoef, A Wagner, M. G. E. M. Ausems, Frederik J. Hes, Hans Morreau, Patrick Franken, H. van der Klift, T H C M Reinards, A H J T Bröcker-Vriends, C. Tops, Ernst J. Kuipers, Juul T. Wijnen, E. B. Gomez Garcia, Martijn H. Breuning, Rolf H. Sijmons, Cora M. Aalfs, Hans F. A. Vasen, Maartje Nielsen, Fred H. Menko, Marjan M. Weiss
Přispěvatelé: VU University medical center, Pathology, Clinical Genetics, Epidemiology, Internal Medicine, Gastroenterology & Hepatology, Medical Imaging and Physical Sciences, Faculty of Medicine and Pharmacy, Faculty of Economic and Social Sciences and Solvay Business School, International Relations and Mobility, Faculty of Arts and Philosophy, Faculty of Psychology and Educational Sciences, Clinical sciences, Medical Genetics, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Human Genetics
Jazyk: angličtina
Rok vydání: 2005
Předmět:
Male
APC GENE
Genetics and epigenetic pathways of disease [NCMLS 6]
Colorectal cancer
DNA Mutational Analysis
SOMATIC G-C->T-A MUTATIONS
Inheritance Patterns
Gene mutation
Gastroenterology
ONSET COLORECTAL-CANCER
DNA Glycosylases
FAMILIAL ADENOMATOUS POLYPOSIS
genetics
Genetics(clinical)
Child
Genetics (clinical)
Molecular diagnosis
prognosis and monitoring [UMCN 1.2]

Netherlands
Genetics
biology
MUTYH-Associated Polyposis
Middle Aged
Phenotype
Adenomatous Polyposis Coli
Female
Colorectal Neoplasms
GENE-MUTATIONS
Adult
Risk
medicine.medical_specialty
Adolescent
Genotype
Adenomatous polyposis coli
NEOPLASIA
Electronic Letter
LESION
Familial adenomatous polyposis
Molecular epidemiology [NCEBP 1]
Breast cancer
Germline mutation
MUTYH
Translational research [ONCOL 3]
Interventional oncology [UMCN 1.5]
Internal medicine
medicine
Humans
Genetic Predisposition to Disease
Germ-Line Mutation
Aged
REPAIR
Hereditary cancer and cancer-related syndromes [ONCOL 1]
business.industry
medicine.disease
GERM-LINE MUTATIONS
biology.protein
business
Zdroj: Journal of Medical Genetics, 42(9). BMJ Publishing Group
Scopus-Elsevier
Journal of Medical Genetics, 42, 9, pp. e54-1-e54
Nielsen, M, Franken, P F, Reinards, T H, Weiss, M M, Wagner, A, van der Klift, H, Kloosterman, S, Houwing-Duistermaat, J J, Aalfs, C M, Ausems, M G, Brocker-Vriends, A H & Gomez Garcia, E B 2005, ' Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP) ', Journal of Medical Genetics, vol. 42, no. 9 . https://doi.org/10.1136/jmg.2005.033217
JOURNAL OF MEDICAL GENETICS, 42(9):54. BMJ PUBLISHING GROUP
Journal of Medical Genetics, 42, e54-1-e54
Journal of medical genetics, 42(9). BMJ Publishing Group
ISSN: 0022-2593
DOI: 10.1136/jmg.2005.033217
Popis: Contains fulltext : 48879.pdf (Publisher’s version ) (Closed access) OBJECTIVE: To investigate the contribution of MYH associated polyposis coli (MAP) among polyposis families in the Netherlands, and the prevalence of colonic and extracolonic manifestations in MAP patients. METHODS: 170 patients with polyposis coli, who previously tested negative for APC mutations, were screened by denaturing gradient gel electrophoresis and direct sequencing to identify MYH germline mutations. RESULTS: Homozygous and compound heterozygous MYH mutations were identified in 40 patients (24%). No difference was found in the percentage of biallelic mutation carriers between patients with 10-99 polyps or 100-1000 polyps (29% in both groups). Colorectal cancer was found in 26 of the 40 patients with MAP (65%) within the age range 21 to 67 years (median 45). Complete endoscopic reports were available for 16 MAP patients and revealed five cases with gastro-duodenal polyps (31%), one of whom also presented with a duodenal carcinoma. Breast cancer occurred in 18% of female MAP patients, significantly more than expected from national statistics (standardised morbidity ratio = 3.75). CONCLUSIONS: Polyp numbers in MAP patients were equally associated with the attenuated and classical polyposis coli phenotypes. Two thirds of the MAP patients had colorectal cancer, 95% of whom were older than 35 years, and one third of a subset of patients had upper gastrointestinal lesions. Endoscopic screening of the whole intestine should be carried out every two years for all MAP patients, starting from age 25-30 years. The frequent occurrence of additional extraintestinal manifestations, such as breast cancer among female MAP patients, should be thoroughly investigated.
Databáze: OpenAIRE